Ke Liu

Ke Liu, a research scientist in the Broad Institute’s Chemical Biology Program, joined the Broad Institute in April 2010. Liu focuses on assay development for high-throughput screening, developing approaches that allow scientists to probe the biology of cells and organisms using vast libraries of small molecules. Liu’s work enables projects that take aim at a variety of diseases, including cancer and Crohn’s disease. 

Liu has collaborated with colleagues on a Crohn’s disease project funded by The Leona M. And Harry B. Helmsley Charitable Trust, working on a number of assays to help identify new mechanisms and small molecules that may have therapeutic potential for this autoimmune disease. She has also taken part in a cancer cell line chemical profiling project and has developed screens for inhibitors of mutations involved in cancer.

Before joining the Broad Institute, Liu completed postdoctoral work at the National Institutes of Health Chemical Genomics Center where she also worked on assay development for high-throughput screening. Liu received her B.S. in molecular and cell biology from the University of Science and Technology of China and her Ph.D. in molecular and cell biology from Vanderbilt University.